CIBC Private Wealth Group
LSTA icon

CIBC Private Wealth Group’s Lisata Therapeutics LSTA Stock Holding History

CIBC Private Wealth Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,702
Closed -$29K – 1076
2022
Q2 		$29K Hold
3,702
– – ﹤0.01% 993
2022
Q1 		$40K Hold
3,702
– – ﹤0.01% 1053
2021
Q4 		$47K Hold
3,702
– – ﹤0.01% 1000
2021
Q3 		$68K Hold
3,702
– – ﹤0.01% 918
2021
Q2 		$89K Hold
3,702
– – ﹤0.01% 1014
2021
Q1 		$107K Hold
3,702
– – ﹤0.01% 1014
2020
Q4 		$79K Hold
3,702
– – ﹤0.01% 966
2020
Q3 		$100K Buy
+3,702
New +$117K ﹤0.01% 858

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group's LSTA Position: Q3 2022 in Review

CIBC Private Wealth Group sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 3,702 shares — an estimated $29K sold.

CIBC Private Wealth Group first reported a position in LSTA in Q3 2020 and held it in 8 quarters. The position peaked at $107K in Q1 2021. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

  • CIBC Private Wealth Group reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,702 Lisata Therapeutics shares in Q3 2022, an estimated $29K.
  • CIBC Private Wealth Group first reported a position in Lisata Therapeutics in Q3 2020 and held it in 8 quarters.
  • CIBC Private Wealth Group's Lisata Therapeutics position peaked at $107K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on CIBC Private Wealth Group's 13F filing for Q3 2022, filed 15 Nov 2022.